Literature DB >> 32078584

Influenza-infected newborn and adult monkeys exhibit a strong primary antibody response to hemagglutinin stem.

Elene Clemens1, Davide Angeletti2, Beth C Holbrook1, Masaru Kanekiyo3, Matthew J Jorgensen4, Barney S Graham3, Jonathan Yewdell5, Martha A Alexander-Miller1.   

Abstract

The specificity of antibodies (Abs) generated against influenza A virus (IAV) infection can significantly alter protection and viral clearance. At present, the impact of age upon this process is relatively unexplored. Here, we evaluated the Ab response in newborn and adult African green monkeys following infection with IAV using a strain that enables us to determine the immunodominance (ID) hierarchy of the Ab response to hemagglutinin (HA), the principal target of protective Abs. This revealed altered ID patterns in the early IgM anti-HA response in newborns versus adults that converged over time. While the IgG ID profiles for HA in newborn and adult monkeys were similar, this was not the case for IgA. Importantly, HA stem-specific Abs were generated robustly and similarly in newborns and adults in terms of quality and quantity. Together, these results demonstrate that newborns and adults can differ in the Ab ID pattern established following infection and that the ID pattern can vary across isotypes. In addition, newborns have the ability to generate potent HA stem-specific Ab responses. Our findings further the understanding of the newborn response to IAV antigens and inform the development of improved vaccines for this at-risk population.

Entities:  

Keywords:  B cells; Immunology

Mesh:

Substances:

Year:  2020        PMID: 32078584      PMCID: PMC7141390          DOI: 10.1172/jci.insight.135449

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  67 in total

1.  The ability of B cells and dendritic cells to present antigen increases during ontogeny.

Authors:  S Muthukkumar; J Goldstein; K E Stein
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

2.  Protecting young babies from influenza.

Authors:  N Macdonald; R Bortolussi
Journal:  Paediatr Child Health       Date:  2009-11       Impact factor: 2.253

3.  Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection.

Authors:  David J DiLillo; Peter Palese; Patrick C Wilson; Jeffrey V Ravetch
Journal:  J Clin Invest       Date:  2016-01-05       Impact factor: 14.808

4.  Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity.

Authors:  Jerome P Jayasekera; E Ashley Moseman; Michael C Carroll
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

5.  Rapid development of broadly influenza neutralizing antibodies through redundant mutations.

Authors:  Leontios Pappas; Mathilde Foglierini; Luca Piccoli; Nicole L Kallewaard; Filippo Turrini; Chiara Silacci; Blanca Fernandez-Rodriguez; Gloria Agatic; Isabella Giacchetto-Sasselli; Gabriele Pellicciotta; Federica Sallusto; Qing Zhu; Elisa Vicenzi; Davide Corti; Antonio Lanzavecchia
Journal:  Nature       Date:  2014-10-05       Impact factor: 49.962

Review 6.  Vaccines against respiratory viral pathogens for use in neonates: opportunities and challenges.

Authors:  Martha A Alexander-Miller
Journal:  J Immunol       Date:  2014-12-01       Impact factor: 5.422

7.  Immunosuppressive CD71+ erythroid cells compromise neonatal host defence against infection.

Authors:  Shokrollah Elahi; James M Ertelt; Jeremy M Kinder; Tony T Jiang; Xuzhe Zhang; Lijun Xin; Vandana Chaturvedi; Beverly S Strong; Joseph E Qualls; Kris A Steinbrecher; Theodosia A Kalfa; Aimen F Shaaban; Sing Sing Way
Journal:  Nature       Date:  2013-11-06       Impact factor: 49.962

8.  Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans.

Authors:  Raffael Nachbagauer; Angela Choi; Ruvim Izikson; Manon M Cox; Peter Palese; Florian Krammer
Journal:  MBio       Date:  2016-01-19       Impact factor: 7.867

9.  Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem.

Authors:  Hyon-Xhi Tan; Sinthujan Jegaskanda; Jennifer A Juno; Robyn Esterbauer; Julius Wong; Hannah G Kelly; Yi Liu; Danielle Tilmanis; Aeron C Hurt; Jonathan W Yewdell; Stephen J Kent; Adam K Wheatley
Journal:  J Clin Invest       Date:  2019-01-22       Impact factor: 14.808

10.  Lamprey VLRB response to influenza virus supports universal rules of immunogenicity and antigenicity.

Authors:  Meghan O Altman; Jack R Bennink; Jonathan W Yewdell; Brantley R Herrin
Journal:  Elife       Date:  2015-08-07       Impact factor: 8.140

View more
  7 in total

Review 1.  Challenges for the Newborn Immune Response to Respiratory Virus Infection and Vaccination.

Authors:  Kali F Crofts; Martha A Alexander-Miller
Journal:  Vaccines (Basel)       Date:  2020-09-24

Review 2.  Precision Vaccine Development: Cues From Natural Immunity.

Authors:  Soumik Barman; Dheeraj Soni; Byron Brook; Etsuro Nanishi; David J Dowling
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

3.  Frailty and Age Impact Immune Responses to Moderna COVID-19 mRNA Vaccine.

Authors:  Charles T Semelka; Michael E DeWitt; Maria W Blevins; Beth C Holbrook; John W Sanders; Martha A Alexander-Miller
Journal:  Res Sq       Date:  2022-08-01

4.  TLR agonists induce sustained IgG to hemagglutinin stem and modulate T cells following newborn vaccination.

Authors:  Elene A Clemens; Beth C Holbrook; Brendan McNeilly; Masaru Kanekiyo; Barney S Graham; Martha A Alexander-Miller
Journal:  NPJ Vaccines       Date:  2022-08-29       Impact factor: 9.399

5.  An R848-Conjugated Influenza Virus Vaccine Elicits Robust Immunoglobulin G to Hemagglutinin Stem in a Newborn Nonhuman Primate Model.

Authors:  Elene A Clemens; Beth C Holbrook; Masaru Kanekiyo; Jonathan W Yewdell; Barney S Graham; Martha A Alexander-Miller
Journal:  J Infect Dis       Date:  2021-07-15       Impact factor: 5.226

Review 6.  Challenges for the Newborn Following Influenza Virus Infection and Prospects for an Effective Vaccine.

Authors:  Martha A Alexander-Miller
Journal:  Front Immunol       Date:  2020-09-16       Impact factor: 7.561

Review 7.  Understanding Antibody Responses in Early Life: Baby Steps towards Developing an Effective Influenza Vaccine.

Authors:  Elene A Clemens; Martha A Alexander-Miller
Journal:  Viruses       Date:  2021-07-17       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.